Endothelial microvesicles carrying Src-rich cargo impair adherens junction integrity and cytoskeleton homeostasis.
Microvesicles (MVs) conduct intercellular communication and impact diverse biological processes by transferring bioactive cargos to other cells. We investigated whether and how endothelial production of MVs contribute to vascular dysfunction during inflammation. We measured the levels and molecular properties of endothelial-derived MVs (EC-MVs) from mouse plasma following a septic injury elicited by cecal ligation and puncture, as well as those from supernatants of cultured endothelial cells stimulated by inflammatory agents including cytokines, thrombin, and complement 5a. The mouse studies showed that sepsis caused a significant increase in total plasma vesicles and VE-cadherin+ EC-MVs compared to sham control. In cultured ECs, different inflammatory agents caused diverse patterns of EC-MV production and cargo contents. When topically applied to endothelial cells, EC-MVs induced a cytoskeleton-junction response characterized by myosin light chain phosphorylation, contractile fiber reorganization, VE-cadherin phosphorylation and adherens junction dissociation, functionally measured as increased albumin transendothelial flux and decreased barrier resistance. The endothelial response was coupled with protein tyrosine phosphorylation promoted by MV cargo containing c-Src kinase, whereas MVs produced from c-Src deficient cells did not exert barrier-disrupting effects. Additionally, EC-MVs contribute to endothelial inflammatory injury by promoting neutrophil-endothelium adhesion and release of neutrophil extracellular traps containing citrullinated histones and myeloperoxidase, a response unaltered by c-Src knockdown. Endothelial-derived microparticles cause endothelial barrier dysfunction by impairing adherens junctions and activating neutrophils. The signaling mechanisms underlying the endothelial cytoskeleton-junction response to EC-MVs involve protein phosphorylation promoted by MV cargo carrying c-Src. However, EC-MV induced neutrophil activation was not dependent on c-Src. Circulating microvesicles derived from blood/vascular cells not only serve as serological markers of disease, but also play a pathogenic role in vascular inflammation. In this study, we characterized the production and molecular signature of microparticles produced by endothelial cells under inflammatory conditions. We discovered that these vesicles carry Src-bearing cargo which interact with endothelial cells inducing cytoskeleton contractile stress and impaired VE-cadherin junction integrity. Additionally, endothelial-derived MVs are capable of stimulating neutrophil-endothelium adhesion and production of neutrophil extracellular traps containing citrullinated histones and myeloperoxidase. These novel findings have the potential to be translated into the development of diagnostic or therapeutic strategies to treat inflammatory disease.